Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics
Laminin-α2-related congenital muscular dystrophy (LAMA2-CMD) is a devastating neuromuscular disease caused by mutations in the LAMA2 gene. These mutations result in the complete absence or truncated expression of the laminin-α2 chain. The α2-chain is a major component of the laminin-211 and laminin-...
Main Authors: | Pamela Barraza-Flores, Christina R. Bates, Ariany Oliveira-Santos, Dean J. Burkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2020.00001/full |
Similar Items
-
Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy
by: Ariany Oliveira-Santos, et al.
Published: (2023-06-01) -
Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD
by: Pamela Barraza-Flores, et al.
Published: (2020-06-01) -
Zebrafish Models of LAMA2-Related Congenital Muscular Dystrophy (MDC1A)
by: Lacramioara Fabian, et al.
Published: (2020-07-01) -
Congenital muscular dystrophy with inflammation: Diagnostic considerations
by: Kaumudi Konkay, et al.
Published: (2016-01-01) -
Brain Dysfunction in LAMA2-Related Congenital Muscular Dystrophy: Lessons From Human Case Reports and Mouse Models
by: Andrea J. Arreguin, et al.
Published: (2020-07-01)